|
|
14598/R1
|
Betaloc Zok 25 mg Tablets
|
Metoprolol succinate
|
AstraZeneca UK Limited
|
Retained
|
Details →
|
|
|
H2008/14598/R1
|
Betaloc Zok 25 mg Tablets
|
Metoprolol succinate
|
AstraZeneca UK Limited
|
Retained
|
Details →
|
|
|
12435/R1
|
Betaloc Zok 50 mg Tablets
|
Metoprolol succinate
|
AstraZeneca UK Limited
|
Retained
|
Details →
|
|
|
H2007/12435/R1
|
Betaloc Zok 50 mg Tablets
|
Metoprolol succinate
|
AstraZeneca UK Limited
|
Retained
|
Details →
|
|
|
H2016/CTD1461/597/R1
|
Bicatero-50
|
Bicalutamide (Form-H1)
|
Hetero labs ltd
|
Retained
|
Details →
|
|
|
H2006/024/17511/R1
|
Biocarb 150mg injection
|
Carboplatin Injection B.P.
|
Zydus Healthcare Limited
|
Retained
|
Details →
|
|
|
H2006/025/17512/R1
|
Biocarb injection 450mg/45ml
|
Carboplatin Injection B.P.
|
Zydus Healthcare Limited
|
Retained
|
Details →
|
|
|
H2005/15552/R1
|
Biotrexate Injection 50mg/2ml
|
Methotrexate Injection U.S.P.
|
Zydus Healthcare Limited
|
Retained
|
Details →
|
|
|
H2001/0130/R1
|
Bispanol Elixir
|
Hyoscine-n-ButylBromide
|
DR. ROHIN VORA
|
Retained
|
Details →
|
|
|
-
|
Bispec 5
|
Solifenacin Succinate
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
CTD472/R1
|
Brilinta 90 mg Tablets
|
Ticagrelor
|
AstraZeneca UK Limited
|
Retained
|
Details →
|
|
|
H2013/CTD472/339/R1
|
Brilinta 90 mg Tablets
|
Ticagrelor
|
AstraZeneca UK Limited
|
Retained
|
Details →
|
|
|
12041; H2002/206/R1
|
Budecort 200 Inhaler
|
Budesonide BP
|
Cipla Ltd
|
Retained
|
Details →
|
|
|
H2002/206/R1
|
Budecort 200 Inhaler
|
Budesonide BP
|
Cipla Ltd
|
Retained
|
Details →
|
|
|
H2006/038/17323/R1
|
Budecort respules 0.5 mg
|
Budesonide BP
|
Cipla Ltd
|
Retained
|
Details →
|
|
|
H2010/20898/236/R1
|
Bupitroy Heavy
|
Bupivacaine Hydrochloride
|
Troikaa Pharmaceuticals Limited
|
Retained
|
Details →
|
|
|
493
|
C OD TABLETS
|
CEFIXIME TRIHYDRATE
|
PSM PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2021/CTD7497/14021
|
C&C 325MG TABLETS
|
CEFIXIME TRIHYDRATE, POTASSIUM CLAVULANATE
|
DOCTOR PHARMA (K) LTD
|
Registered
|
Details →
|
|
|
H2018/CTD5414/358ER/R1
|
C-AMPI 500 INJECTION
|
Ampicillin sodium
|
CROWN HEALTHCARE
|
Retained
|
Details →
|
|
|
CTD 1561
|
C-CLAV SUSPENSION
|
CEFIXIME TRIHYDRATE USP EQUIV. TO CEFIXIME AND CLAVULANATE POTASSIUM USP EQUIV. TO CLAVULANIC ACID
|
WIN-PHARMA LIMITED
|
Registered
|
Details →
|